Munafa Stock Market Course + Intraday & FNO calls 
SPARC_BE announcements Sun Pharma Adv.res.co.ltd announcements and dividends declared NSE
Sun Pharma Adv.res.co.ltd Complete list of announcements declared & dividend announcements by Sun Pharma Adv.res.co.ltd SPARC_BE
Sun Pharma Adv.res.co.ltd SPARC_BE listed on NSE and deals inAnnouncements and dividends declared by Sun Pharma Adv.res.co.ltd SPARC_BE
US FDA issues 'Official Action Indicated' status to Sun Pharma’s Baska facility after inspection
Sun Pharmaceutical Industries Ltd announced that its Baska manufacturing facility has been classified as Official Action Indicated (OAI) by the US FDA following a recent inspection. Despite this classification, the company confirmed that supplies to the US
Announcement as on 18 December 2025
Delhi HC allows Sun Pharma to manufacture, export its own weight loss drug
The Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made by Novo Nordisk as Wegovy. However, the court barred Sun from selling the drug in India until March 2026, when Novo No
Announcement as on 10 December 2025
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Review Voucher. The stock jumped over 11%, extending Tuesday’s 20% rally, even as analysts caution about overbought tech
Announcement as on 03 December 2025
Sun Pharma unit to invest Rs 3,000 cr on new plant in Madhya Pradesh
Sun Pharmaceutical Industries' subsidiary, Sun Pharma Laboratories Ltd, has approved a Rs 3,000 crore investment for a new greenfield formulations manufacturing facility in Madhya Pradesh. This significant expansion by the Mumbai-based drug major aims to b
Announcement as on 03 December 2025
Sun Pharma brings global psoriasis drug ILUMYA to Indian market
Sun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This novel treatment, Tildrakizumab, has a proven track record globally for providing significant and sustained skin clearanc
Announcement as on 01 December 2025
Announcements by Sun Pharma Adv.res.co.ltd first page | Next page |
SPARC_BE Sun Pharma Adv.res.co.ltd current price & indicator signals
Recent prices of SPARC_BE Sun Pharma Adv.res.co.ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Mon Apr 2024 | 315.95 | 315.95 to 315.95 | -4.99% | 0.34 times |
| 19 Fri Apr 2024 | 332.55 | 332.55 to 332.55 | -5% | 0.23 times |
| 18 Thu Apr 2024 | 350.05 | 350.05 to 350.05 | -4.99% | 0.3 times |
| 16 Tue Apr 2024 | 368.45 | 368.45 to 368.45 | -5% | 0.23 times |
| 15 Mon Apr 2024 | 387.85 | 387.85 to 387.85 | -5% | 0.16 times |
| 12 Fri Apr 2024 | 408.25 | 408.25 to 408.25 | -4.99% | 0.2 times |
| 10 Wed Apr 2024 | 429.70 | 429.70 to 429.70 | -5% | 0.24 times |
| 09 Tue Apr 2024 | 452.30 | 437.30 to 472.80 | -0.66% | 1.95 times |
| 08 Mon Apr 2024 | 455.30 | 455.30 to 455.30 | 4.99% | 1.7 times |
| 05 Fri Apr 2024 | 433.65 | 410.00 to 433.65 | 5% | 2.82 times |
| 04 Thu Apr 2024 | 413.00 | 396.00 to 413.00 | 5% | 2.17 times |
| 03 Wed Apr 2024 | 393.35 | 375.00 to 395.00 | 2.37% | 1.06 times |
Videos related to: SPARC_BE announcements Sun Pharma Adv.res.co.ltd announcements and dividends declared NSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
